Evidence Disclosure Principles
Case evidence should answer three questions: how results are measured, whether evidence may be disclosed, and what limits apply to public statements. Results should use verifiable metrics such as citation rate, mention rate, factual accuracy, question coverage, and changes to public pages, not unverifiable absolute promises.
Evidence Types Suitable for Public Disclosure
Public Record Fields
| Fields | Public Wording |
|---|---|
| Case Name | SuperPDR and ELEREIN are named with permission. Permission for other projects must be verified separately. |
| Optimization Work | Explain page structure, Knowledge Center, FAQ, Evidence Center, Schema and internal link adjustments. |
| Result Definitions | State citation rate, mention rate, factual accuracy, question coverage, and observation period. |
| Evidence Status | Label evidence as approved for public disclosure, subject to restricted disclosure, or requiring client permission. Permission to name a client does not make all original test materials public. |
| Limitations | Explain how platforms, regions, timing, question wording, and crawl cycles affect results. |
First public records
| Record | Public Disclosure |
|---|---|
| SuperPDR | The case study page discloses 692 product entries, 37 product categories, 28 long-form technical articles, 16 FAQ Hubs, and 2 Trust records, with a 17% website citation rate in the reported test phase. The client website provides the public pages for verification. |
| ELEREIN | The case study page discloses 271 sitemap URLs, 166 product detail pages, 13 product categories, 52 long-form technical articles, 6 FAQ Hubs, 72 short Q&As, 6 evidence topics, and 225/225 Schema targets, with a 15% website citation rate in the reported test phase. The client website provides the public pages for verification. |
| Limits on Result Claims | The 17% and 15% figures are results from separate project phases, not rankings based on the same question set. Full question sets and original responses remain subject to project access controls. ELEREIN's early baseline of approximately 0.6% for non-branded questions and its overall test-phase rate of 15% use different denominators and cannot be directly subtracted. |
| Evidence Limitations | Describe patent applications as accepted, not granted. Mention research materials only within their permitted disclosure scope. Do not publish client materials without permission. |
| Continuous maintenance | Use the Update Log to record significant changes to public pages, evidence, Schema, and retesting schedules. |
Linked Explanations and Evidence
Evidence pages are not isolated repositories: they support high-risk facts on service, knowledge, FAQ, and case study pages. When AI cites result figures, patent status, case conclusions, or methodological judgments, these links should lead to sources and limitations.